Wenbing Xie

1.6k citations
19 papers · 739 indexed · h-index 13
    • Epigenetics and DNA Methylation 12
    • RNA modifications and cancer 8
    • Genomics and Chromatin Dynamics 7
    • Cancer-related gene regulation 5
    • DNA Repair Mechanisms 2
    • CRISPR and Genetic Engineering 2
    • Histone Deacetylase Inhibitors Research 2
    • Telomeres, Telomerase, and Senescence 3

Wenbing Xie

18 papers receiving 736 citations

Peers

Wenbing Xie
Comparison fields: 5 of 77
  • Molecular Biology 636
  • Aging 13
  • Cancer Research 109
  • Oncology 94
  • Immunology 55
Replace Jinsuk Kang with:
Jinsuk Kang United States
Eva M. Riising Denmark
Martin D. Burkhalter Germany
Kristen L. Meerbrey United States
Jung S. Byun United States
Michelle S. Levine United States
Kazutsune Yamagata Japan
Takahiro Naiki Japan
Virginie Mougey France
Angela Nakauka‐Ddamba United States
Wenbing Xie relative to Jinsuk Kang United States Jinsuk Kang's profile →
Citations per field
00.5×3.0×
Jinsuk Kang · 1×
Citations per year

Countries citing papers authored by Wenbing Xie

Since Specialization
Citations

This map shows the geographic impact of Wenbing Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbing Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbing Xie more than expected).

Fields of papers citing papers by Wenbing Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenbing Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbing Xie. The network helps show where Wenbing Xie may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Wenbing Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wenbing Xie Line = papers co-authored together Wenbing Xie links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1 20255
2 20250
3 20252
4 202313
5 2019101
6 201927
7 201886
8 20181
9 201829
10 2017101
11 2017141
12 201616
13 20161
14 20151
15 201518
16 201317
17 201312
18 201373
19 201295

About Wenbing Xie

Wenbing Xie is a scholar working on Molecular Biology, Geriatrics and Gerontology and Physiology, having authored 19 papers that have together received 739 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (12 papers), RNA modifications and cancer (8 papers), Genomics and Chromatin Dynamics (7 papers), Cancer-related gene regulation (5 papers), Telomeres, Telomerase, and Senescence (3 papers), DNA Repair Mechanisms (2 papers), CRISPR and Genetic Engineering (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Molecular Biology (636 citations), Aging (13 citations) and Cancer Research (109 citations). Wenbing Xie has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Stephen B. Baylin, Hariharan Easwaran, Limin Xia, Ray-Whay Chiu Yen, Yi Cai, Yang W. Zhang, Wei Tao, Cynthia A. Zahnow, Te Ling and Qiaoyun Zhu.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026